Actions of calcium ions and a calcium-influx blocker on basal and TRH- and GnRH-stimulated hormone release in patients with pituitary adenomas

M. Davis, B. Nassberg, J. L C Borges, A. Iranmanesh, G. Lizzaralde, R. J. Santen, C. Drake, A. D. Rogol, D. L. Kaiser, M. O. Thorner, Johannes D Veldhuis

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

We investigated the influence of calcium ions on the secretion of anterior pituitary hormones basally and in response to exogenous hypothalamic releasing factors in 6 men with pituitary tumors. To this end, concentrations of LH, FSH, TSH, growth hormone and prolactin were measured in blood collected at 10-min intervals basally and during a continuous infusion of combined TRH (2 μg/min) and GnRH (1 μg/min). Study sessions were randomized to iv saline, calcium, or diltiazem infusions or oral diltiazem administration. Our results indicate that in contrast to responses in normal men, iv calcium injections do not suppress circulating prolactin concentrations in patients with prolactin-secreting pituitary tumors. Moreover, neither oral diltiazem administration for one week nor acute iv diltiazem infusion suppressed the hyperprolactinemia of tumor patients. However, there were significant effects of drug and calcium treatments on serum concentrations of FSH, GH and testosterone, but not LH or TSH. Moreover, during GnRH-TRH stimulation, there were significant differences in LH, TSH, and testosterone responses in tumor patients compared to normal men. In summary, iv calcium infusion was associated with invariant basal release of anterior pituitary tumoral hormones in patients with pituitary adenomas. However, there were significant differences in the GnRH/TRH-stimulated release of certain anterior pituitary hormones in tumor patients compared to normal men in response to iv calcium and the calcium-channel antagonist, diltiazem.

Original languageEnglish (US)
Pages (from-to)427-433
Number of pages7
JournalJournal of Endocrinological Investigation
Volume10
Issue number5
StatePublished - 1987
Externally publishedYes

Fingerprint

Pituitary Neoplasms
Diltiazem
Gonadotropin-Releasing Hormone
Hormones
Ions
Anterior Pituitary Hormones
Calcium
Prolactin
Oral Administration
Testosterone
Pituitary Hormone-Releasing Hormones
Neoplasms
Hyperprolactinemia
Calcium Channel Blockers
Growth Hormone
Injections
Serum
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Endocrinology

Cite this

Davis, M., Nassberg, B., Borges, J. L. C., Iranmanesh, A., Lizzaralde, G., Santen, R. J., ... Veldhuis, J. D. (1987). Actions of calcium ions and a calcium-influx blocker on basal and TRH- and GnRH-stimulated hormone release in patients with pituitary adenomas. Journal of Endocrinological Investigation, 10(5), 427-433.

Actions of calcium ions and a calcium-influx blocker on basal and TRH- and GnRH-stimulated hormone release in patients with pituitary adenomas. / Davis, M.; Nassberg, B.; Borges, J. L C; Iranmanesh, A.; Lizzaralde, G.; Santen, R. J.; Drake, C.; Rogol, A. D.; Kaiser, D. L.; Thorner, M. O.; Veldhuis, Johannes D.

In: Journal of Endocrinological Investigation, Vol. 10, No. 5, 1987, p. 427-433.

Research output: Contribution to journalArticle

Davis, M, Nassberg, B, Borges, JLC, Iranmanesh, A, Lizzaralde, G, Santen, RJ, Drake, C, Rogol, AD, Kaiser, DL, Thorner, MO & Veldhuis, JD 1987, 'Actions of calcium ions and a calcium-influx blocker on basal and TRH- and GnRH-stimulated hormone release in patients with pituitary adenomas', Journal of Endocrinological Investigation, vol. 10, no. 5, pp. 427-433.
Davis, M. ; Nassberg, B. ; Borges, J. L C ; Iranmanesh, A. ; Lizzaralde, G. ; Santen, R. J. ; Drake, C. ; Rogol, A. D. ; Kaiser, D. L. ; Thorner, M. O. ; Veldhuis, Johannes D. / Actions of calcium ions and a calcium-influx blocker on basal and TRH- and GnRH-stimulated hormone release in patients with pituitary adenomas. In: Journal of Endocrinological Investigation. 1987 ; Vol. 10, No. 5. pp. 427-433.
@article{e4391216383642fea0bcced97c9081e3,
title = "Actions of calcium ions and a calcium-influx blocker on basal and TRH- and GnRH-stimulated hormone release in patients with pituitary adenomas",
abstract = "We investigated the influence of calcium ions on the secretion of anterior pituitary hormones basally and in response to exogenous hypothalamic releasing factors in 6 men with pituitary tumors. To this end, concentrations of LH, FSH, TSH, growth hormone and prolactin were measured in blood collected at 10-min intervals basally and during a continuous infusion of combined TRH (2 μg/min) and GnRH (1 μg/min). Study sessions were randomized to iv saline, calcium, or diltiazem infusions or oral diltiazem administration. Our results indicate that in contrast to responses in normal men, iv calcium injections do not suppress circulating prolactin concentrations in patients with prolactin-secreting pituitary tumors. Moreover, neither oral diltiazem administration for one week nor acute iv diltiazem infusion suppressed the hyperprolactinemia of tumor patients. However, there were significant effects of drug and calcium treatments on serum concentrations of FSH, GH and testosterone, but not LH or TSH. Moreover, during GnRH-TRH stimulation, there were significant differences in LH, TSH, and testosterone responses in tumor patients compared to normal men. In summary, iv calcium infusion was associated with invariant basal release of anterior pituitary tumoral hormones in patients with pituitary adenomas. However, there were significant differences in the GnRH/TRH-stimulated release of certain anterior pituitary hormones in tumor patients compared to normal men in response to iv calcium and the calcium-channel antagonist, diltiazem.",
author = "M. Davis and B. Nassberg and Borges, {J. L C} and A. Iranmanesh and G. Lizzaralde and Santen, {R. J.} and C. Drake and Rogol, {A. D.} and Kaiser, {D. L.} and Thorner, {M. O.} and Veldhuis, {Johannes D}",
year = "1987",
language = "English (US)",
volume = "10",
pages = "427--433",
journal = "Journal of Endocrinological Investigation",
issn = "0391-4097",
publisher = "Editrice Kurtis s.r.l.",
number = "5",

}

TY - JOUR

T1 - Actions of calcium ions and a calcium-influx blocker on basal and TRH- and GnRH-stimulated hormone release in patients with pituitary adenomas

AU - Davis, M.

AU - Nassberg, B.

AU - Borges, J. L C

AU - Iranmanesh, A.

AU - Lizzaralde, G.

AU - Santen, R. J.

AU - Drake, C.

AU - Rogol, A. D.

AU - Kaiser, D. L.

AU - Thorner, M. O.

AU - Veldhuis, Johannes D

PY - 1987

Y1 - 1987

N2 - We investigated the influence of calcium ions on the secretion of anterior pituitary hormones basally and in response to exogenous hypothalamic releasing factors in 6 men with pituitary tumors. To this end, concentrations of LH, FSH, TSH, growth hormone and prolactin were measured in blood collected at 10-min intervals basally and during a continuous infusion of combined TRH (2 μg/min) and GnRH (1 μg/min). Study sessions were randomized to iv saline, calcium, or diltiazem infusions or oral diltiazem administration. Our results indicate that in contrast to responses in normal men, iv calcium injections do not suppress circulating prolactin concentrations in patients with prolactin-secreting pituitary tumors. Moreover, neither oral diltiazem administration for one week nor acute iv diltiazem infusion suppressed the hyperprolactinemia of tumor patients. However, there were significant effects of drug and calcium treatments on serum concentrations of FSH, GH and testosterone, but not LH or TSH. Moreover, during GnRH-TRH stimulation, there were significant differences in LH, TSH, and testosterone responses in tumor patients compared to normal men. In summary, iv calcium infusion was associated with invariant basal release of anterior pituitary tumoral hormones in patients with pituitary adenomas. However, there were significant differences in the GnRH/TRH-stimulated release of certain anterior pituitary hormones in tumor patients compared to normal men in response to iv calcium and the calcium-channel antagonist, diltiazem.

AB - We investigated the influence of calcium ions on the secretion of anterior pituitary hormones basally and in response to exogenous hypothalamic releasing factors in 6 men with pituitary tumors. To this end, concentrations of LH, FSH, TSH, growth hormone and prolactin were measured in blood collected at 10-min intervals basally and during a continuous infusion of combined TRH (2 μg/min) and GnRH (1 μg/min). Study sessions were randomized to iv saline, calcium, or diltiazem infusions or oral diltiazem administration. Our results indicate that in contrast to responses in normal men, iv calcium injections do not suppress circulating prolactin concentrations in patients with prolactin-secreting pituitary tumors. Moreover, neither oral diltiazem administration for one week nor acute iv diltiazem infusion suppressed the hyperprolactinemia of tumor patients. However, there were significant effects of drug and calcium treatments on serum concentrations of FSH, GH and testosterone, but not LH or TSH. Moreover, during GnRH-TRH stimulation, there were significant differences in LH, TSH, and testosterone responses in tumor patients compared to normal men. In summary, iv calcium infusion was associated with invariant basal release of anterior pituitary tumoral hormones in patients with pituitary adenomas. However, there were significant differences in the GnRH/TRH-stimulated release of certain anterior pituitary hormones in tumor patients compared to normal men in response to iv calcium and the calcium-channel antagonist, diltiazem.

UR - http://www.scopus.com/inward/record.url?scp=0023203635&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023203635&partnerID=8YFLogxK

M3 - Article

VL - 10

SP - 427

EP - 433

JO - Journal of Endocrinological Investigation

JF - Journal of Endocrinological Investigation

SN - 0391-4097

IS - 5

ER -